These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35579499)

  • 1. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary.
    Weitzman ER; Sherman AC; Levy O
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S46-S50. PubMed ID: 35579499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System.
    Weitzman ER; Sherman AC; Levy O
    Front Public Health; 2021; 9():695807. PubMed ID: 34336774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.
    Powell J; Piszczatoski CR
    Ann Pharmacother; 2022 Sep; 56(9):1058-1064. PubMed ID: 35012364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?
    Anderson EJ; Campbell JD; Creech CB; Frenck R; Kamidani S; Munoz FM; Nachman S; Spearman P
    Clin Infect Dis; 2021 Jul; 73(2):336-340. PubMed ID: 32945335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Dowling DJ; Levy O
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S30-S36. PubMed ID: 35512145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine.
    Fraley E; LeMaster C; Khanal S; Banerjee D; Pastinen T; Grundberg E; Selvarangan R; Bradley T
    Clin Infect Dis; 2022 Aug; 75(1):e902-e904. PubMed ID: 34551091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update From the Advisory Committee on Immunization Practices.
    O Leary ST; Maldonado YA; Kimberlin DW
    J Pediatric Infect Dis Soc; 2020 Dec; 9(6):645-649. PubMed ID: 33180938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in First Dose COVID-19 Vaccination Coverage among Children 5-11 Years of Age, United States.
    Murthy NC; Zell E; Fast HE; Murthy BP; Meng L; Saelee R; Vogt T; Chatham-Stephens K; Ottis C; Shaw L; Gibbs-Scharf L; Harris L; Chorba T
    Emerg Infect Dis; 2022 May; 28(5):986-989. PubMed ID: 35226801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.
    Chavda VP; Bezbaruah R; Athalye M; Parikh PK; Chhipa AS; Patel S; Apostolopoulos V
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will vaccination refusal prolong the war on SARS-CoV-2?
    Marcec R; Majta M; Likic R
    Postgrad Med J; 2021 Mar; 97(1145):143-149. PubMed ID: 33115909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children.
    Kao CM; Orenstein WA; Anderson EJ
    Clin Infect Dis; 2021 Feb; 72(3):515-518. PubMed ID: 33527122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enlightening from optimizing post-authorization safety monitoring system of SARS-CoV-2 vaccines in major economies worldwide].
    Wang SY; Pan XJ; Deng X; Fu J; Zhang HJ; Ding LL; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):1096-1104. PubMed ID: 37482744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.
    Nguyen S; Bastien E; Chretien B; Sassier M; Defer G; Nehme A; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Morice PM
    Ann Neurol; 2022 Dec; 92(6):1080-1089. PubMed ID: 36054163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
    Jain E; Donowitz JR; Aarons E; Marshall BC; Miller MP
    Emerg Infect Dis; 2022 May; 28(5):990-993. PubMed ID: 35275051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression.
    Mohanraj D; Whitelegg A
    Int Arch Allergy Immunol; 2022; 183(8):888-906. PubMed ID: 35390803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccination Coverage, Intent, Knowledge, Attitudes, and Beliefs among Essential Workers, United States.
    Nguyen KH; Yankey D; Coy KC; Brookmeyer KA; Abad N; Guerin R; Syamlal G; Lu PJ; Baack BN; Razzaghi H; Okun A; Singleton JA
    Emerg Infect Dis; 2021 Nov; 27(11):2908-2913. PubMed ID: 34586060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
    Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
    Front Immunol; 2021; 12():728021. PubMed ID: 34646267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.